Purchase this article with an account.
E. Hoyama, S.A. Schellini, H.O. Stollf, V. Nakajima, C.R. Padovani; Lacrimal Excretory System Sequelae in Patients Treated for Leishmaniasis . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5070.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: The purpose of the present study is to evaluate the frequency of lacrimal excretory system sequelae in patients treated for leishmaniasis. Methods: Forty–five patients treated for leishmaniasis (90 nasolacrimal ducts) were submitted to lacrimal excretory system evaluation. All were evaluated by Jones I Test and when the test was abnormal, dacryocystography and nasal endoscopy were performed. Results: The majority of patients evaluated had had the cutaneous form (64.4%) of leishmaniasis, however, 69.23% of the patients with lacrimal excretory system alterations had had the mucocutaneous form of infection before treatment. In these, the most common alteration detected was bilateral permeable and dilated nasolacrimal ducts (92.30%). Only 3.84% (1/26) of the nasolacrimal ducts evaluated were obstructed. Nasal endoscopy showed cornetus hypertrophy (53.84%), septum deviation (53.84%) and nasal septum perforation (23.07%). Conclusions: Permeable and dilated lacrimal excretory system were the most common sequelae related to leishmaniasis infection.
This PDF is available to Subscribers Only